Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: EMERALD INNOVATIONS, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-12-06 to 2026-05-30
Current total value of award: $1956704
Description: THE GOAL OF THIS PROJECT IS TO DEVELOP AN OBJECTIVE, QUANTITATIVE, AND USER-FRIENDLY DIGITAL ENDPOINT TO ASSESS NOCTURNAL SCRATCHING IN CHILDREN WITH ATOPIC DERMATITIS. THIS ENDPOINT WILL FULFILL A CRUCIAL UNMET NEED BY FOR ASSESSING THE EFFICACY